EMA Authorised: Karvea (irbesartan) — Sanofi Winthrop Industrie

View source ↗

Summary

The European Medicines Agency authorised Karvea (irbesartan) for the treatment of hypertension, with Sanofi Winthrop Industrie as the marketing authorization ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Karvea (irbesartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Sanofi Winthrop Industrie. Decision date: 15/01/2026